Aberrant RL2 O-GlcNAc antibody reactivity against serum-IgA1 of patients with colorectal cancer. Verathamjamras C, Sriwitool TE, Netsirisawan P, Chaiyawat P, Chokchaichamnankit D, Prasongsook N, Srisomsap C, Svasti J, Champattanachai V*. Glycoconj J. 2021 Feb;38(1):55-65.
Aberrant RL2 O-GlcNAc antibody reactivity against serum-IgA1 of patients with colorectal cancer.
Verathamjamras C, Sriwitool TE, Netsirisawan P, Chaiyawat P, Chokchaichamnankit D, Prasongsook N, Srisomsap C, Svasti J, Champattanachai V*.
Glycoconj J. 2021 Feb;38(1):55-65.
Related Posts
28 Nov 2006
Proteomic studies of galectin-3 expression in human thyroid diseases by immunodetection. Subhasitanont, P, Srisomsap, C*, Punyarit P, Svasti J. Cancer Genomics Proteomics 2006 Nov-Dec;3(6):389-94.
View More
28 Jun 2003
Involvement of beta interferon in enhancing inducible nitric oxide synthase production and antimicrobial activity of Burkholderia pseudomallei-infected macrophages. Utaisincharoen P, Anuntagool N, Limposuwan K, Chaisuriya P, Sirisinha S Infect Immun71p3053-7(2003 Jun)
View More
Recent Posts
24 Jun 2024
Breast cancer prevention by dietary polyphenols: Microemulsion formulation and in vitro Studies Cristy GP, Liana D, Chatwichien J, Aonbangkhen C, Srisomsap C, Phanumartwiwath A Sci Pharm. 2024;9(2):25.
View More
